We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,389

Autonomous Vehicles 2016
  • Borden Ladner Gervais LLP
  • Canada, USA
  • July 27 2016

Some of the largest and most influential companies in the world have made billion-dollar investments in “driverless transport” - and these are not

ACI Medical Devices Boot Camp Features New CDRH Director of Clinical Compliance Robin Newman
  • McGuireWoods LLP
  • USA
  • July 26 2016

On July 21-22, the American Conference Institute (ACI) held its Fourth Annual FDA Boot Camp: Medical Devices Edition in Chicago, Illinois. The

FDA Deep Dive: Real Life Implications of FDA NEST Program Explored
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 19 2016

In our Israel Connect Summer 2016 edition we summarized the FDA's post-market surveillance data programs, including the NEST program designed to

FDA Releases Two Draft Guidances on Next Generation Sequencing
  • Hogan Lovells
  • USA
  • July 15 2016

On July 6, 2016, the FDA announced two new draft guidances on the oversight of next generation sequencing (NGS)-based in vitro diagnostic tests

FDA Issues Final Rule on Use of Stand-Alone Symbols in Medical Device Labeling
  • Hogan Lovells
  • USA
  • June 24 2016

On June 14, 2016, the Food and Drug Administration ("FDA" or "the agency") issued a final rule entitled Use of Symbols in Labeling. Historically, FDA

FDA Issues Draft Guidance on Benefit-Risk Factors to Consider Regarding Medical Device Availability, Compliance, and Enforcement
  • Barnes & Thornburg LLP
  • USA
  • June 21 2016

The Food and Drug Administration (FDA) recently issued a brief draft guidance titled "Factors to Consider Regarding Benefit-Risk in Medical Device

FDA Issues First Draft Guidance on NGS-Based Diagnostic Devices
  • Hogan Lovells
  • USA
  • June 2 2016

On May 13, 2016, the U.S. Food and Drug Administration (FDA or the Agency) issued a new draft guidance entitled, "Infectious Disease Next Generation

Pharmaceutical & Medical Device Regulatory Update, Vol. III, Issue 4
  • Jones Day
  • USA
  • May 31 2016

Earlier this month, four Republican SenatorsLamar Alexander (TN), Richard Burr (NC), Johnny Isakson (GA), and Orrin Hatch (UT)sent a letter to FDA

FDA addresses postmarket surveillance for medical devices in final guidance
  • Barnes & Thornburg LLP
  • USA
  • May 31 2016

The Food and Drug Administration (FDA) recently issued a final guidance addressing postmarket surveillance for medical devices. The FDA is authorized

International Corporate Crime Conference Report
  • CMS
  • European Union, United Kingdom, USA
  • May 27 2016

Allegations of fraud, corruption, money laundering, tax evasion and other forms of financial crime involving senior public figures and companies are